DBV Technologies S.A.
publicly owned French biopharmaceutical firm headquartered in Bagneux, France
DBVT Nasdaq
SEC CIK 1613780
Follow DBV Technologies S.A.
Weekly email: filings, results, news
News
No stories filed under DBV Technologies S.A. yet — coverage appears here as the news feed clusters it.